GLAUKOS CORPORATION

Lobbying for GLAUKOS CORPORATION · Research and product development

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 10, 2026

Expenses

$280,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

California

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 5

HR 3514
Improving Seniors’ Timely Access to Care Act of 2025
S 1816
Improving Seniors’ Timely Access to Care Act of 2025
HR 2527
Early Detection of Vision Impairments for Children Act of 2025
HR 1261
Land and Water Conservation Fund Water Amendments Act of 2025
S 3302
Mikaela Naylon Give Kids a Chance Act of 2025

Lobbying activity 2

Medicare/Medicaid

H.R. 3514/ S. 1816 Improving Seniors Timely Access to Care Act of 2025 H.R. 2527 Early Detection of Vision Impairments for Children Act of 2025

Medical/Disease Research/Clinical Labs

Legislation regarding FDA regulation of combination products H.R. 1261/ S. 3302 Mikaela Naylon Give Kids a Chance Act Bill

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.